Other chlamydial infection of lower genitourinary tract
ICD-10 A56.09 is a billable code used to indicate a diagnosis of other chlamydial infection of lower genitourinary tract.
Chlamydia infections are among the most common sexually transmitted infections (STIs) worldwide, primarily caused by the bacterium Chlamydia trachomatis. The lower genitourinary tract includes the urethra and cervix, where infections can lead to urethritis in men and cervicitis in women. Symptoms may include abnormal discharge, dysuria, and pelvic pain, although many individuals remain asymptomatic. The diagnosis is typically confirmed through nucleic acid amplification tests (NAATs) or culture methods. Treatment usually involves antibiotics such as azithromycin or doxycycline. It is crucial to screen sexually active individuals, especially those under 25, and to conduct contact tracing to prevent further transmission. This code is used when the infection does not fall under more specific categories of chlamydial infections, indicating a need for careful clinical assessment and documentation to ensure accurate coding.
Detailed patient history, laboratory results, and treatment plans.
Diagnosis and management of STIs, including chlamydia.
Consideration of co-infections and patient follow-up.
Documentation of pelvic exams, symptoms, and treatment regimens.
Routine screening and treatment of chlamydia in sexually active women.
Importance of discussing sexual health and partner notification.
Used for laboratory confirmation of chlamydia infection.
Document the reason for testing and patient consent.
Infectious disease specialists should ensure comprehensive STI screening.
Common symptoms include abnormal discharge, dysuria, and pelvic pain, but many individuals may be asymptomatic.
Chlamydia is diagnosed through nucleic acid amplification tests (NAATs) or culture methods.
The recommended treatment typically involves antibiotics such as azithromycin or doxycycline.
